TREU JESSE I

CIK 00010134256 companiesPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001013425

Recent Transactions

46 trades

Other
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2006-12-12+9,783→ 20,458 total
Other
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2006-12-12−581,176→ 1,954,450 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2006-12-12$25.62/sh−12,900→ 21,068 total
Other
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2006-12-12−581,176→ 1,954,450 total
Other
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2006-12-12+9,783→ 20,458 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2006-12-12$25.62/sh−12,900→ 21,068 total
Conversion
CADENCE PHARMACEUTICALS INC
Series A-2 Preferred Stock
2006-10-30−6,297,638→ 0 total
Conversion
CADENCE PHARMACEUTICALS INC
Series A-1 Preferred Stock
2006-10-30−3,947,061→ 0 total
Conversion
CADENCE PHARMACEUTICALS INC
Series A-2 Preferred Stock
2006-10-30−67,492→ 0 total
Conversion
CADENCE PHARMACEUTICALS INC
Series A-1 Preferred Stock
2006-10-30−3,947,061→ 0 total
Conversion
CADENCE PHARMACEUTICALS INC
Series A-3 Preferred Stock
2006-10-30−12,367,456→ 0 total
Conversion
CADENCE PHARMACEUTICALS INC
Series A-1 Preferred Stock
2006-10-30−42,301→ 0 total
Conversion
CADENCE PHARMACEUTICALS INC
Series A-2 Preferred Stock
2006-10-30−67,492→ 0 total
Conversion
CADENCE PHARMACEUTICALS INC
Series A-2 Preferred Stock
2006-10-30−6,297,638→ 0 total
Conversion
CADENCE PHARMACEUTICALS INC
Series A-3 Preferred Stock
2006-10-30−132,544→ 0 total
Conversion
CADENCE PHARMACEUTICALS INC
Common Stock
2006-10-30+5,653,038→ 5,653,038 total
Conversion
CADENCE PHARMACEUTICALS INC
Common Stock
2006-10-30+60,584→ 60,584 total
Conversion
CADENCE PHARMACEUTICALS INC
Common Stock
2006-10-30+5,653,038→ 5,653,038 total
Conversion
CADENCE PHARMACEUTICALS INC
Series A-3 Preferred Stock
2006-10-30−12,367,456→ 0 total
Conversion
CADENCE PHARMACEUTICALS INC
Common Stock
2006-10-30+60,584→ 60,584 total
Conversion
CADENCE PHARMACEUTICALS INC
Series A-3 Preferred Stock
2006-10-30−132,544→ 0 total
Conversion
CADENCE PHARMACEUTICALS INC
Series A-1 Preferred Stock
2006-10-30−42,301→ 0 total
Conversion
Paratek Pharmaceuticals, Inc.
Series A-2 Preferred Stock
2006-05-15+13,480→ 0 total
Purchase
Paratek Pharmaceuticals, Inc.
Common Stock
2006-05-15$6.50/sh+450,887→ 4,151,823 total
Conversion
Paratek Pharmaceuticals, Inc.
Series B Preferred Stock
2006-05-15+20,102→ 0 total
Conversion
Paratek Pharmaceuticals, Inc.
Series C Preferred Stock
2006-05-15+1,652,841→ 0 total
Conversion
Paratek Pharmaceuticals, Inc.
Series A-1 Preferred Stock
2006-05-15+570,647→ 0 total
Conversion
Paratek Pharmaceuticals, Inc.
Series A-2 Preferred Stock
2006-05-15+570,647→ 0 total
Purchase
Paratek Pharmaceuticals, Inc.
Common Stock
2006-05-15$6.50/sh+10,651→ 98,075 total
Conversion
Paratek Pharmaceuticals, Inc.
Series B Preferred Stock
2006-05-15+850,977→ 0 total
Conversion
Paratek Pharmaceuticals, Inc.
Common Stock
2006-05-15+86,106→ 87,424 total
Conversion
Paratek Pharmaceuticals, Inc.
Series C Preferred Stock
2006-05-15+39,044→ 0 total
Conversion
Paratek Pharmaceuticals, Inc.
Common Stock
2006-05-15+3,645,112→ 3,700,936 total
Conversion
Paratek Pharmaceuticals, Inc.
Series A-1 Preferred Stock
2006-05-15+13,480→ 0 total
Conversion
SANTARUS INC
Series D Preferred Stock
2004-04-06−1,111,402→ 0 total
Conversion
SANTARUS INC
Series D Preferred Stock
2004-04-06−1,111,402→ 0 total
Conversion
SANTARUS INC
Series C Preferred Stock
2004-04-06−1,617,795→ 0 total
Conversion
SANTARUS INC
Series D Preferred Stock
2004-04-06−26,254→ 0 total
Conversion
SANTARUS INC
Series C Preferred Stock
2004-04-06−38,217→ 0 total
Conversion
SANTARUS INC
Common Stock
2004-04-06+64,471→ 64,471 total
Conversion
SANTARUS INC
Common Stock
2004-04-06+2,729,197→ 2,729,197 total
Conversion
SANTARUS INC
Common Stock
2004-04-06+2,729,197→ 2,729,197 total
Conversion
SANTARUS INC
Series D Preferred Stock
2004-04-06−26,254→ 0 total
Conversion
SANTARUS INC
Series C Preferred Stock
2004-04-06−38,217→ 0 total
Conversion
SANTARUS INC
Common Stock
2004-04-06+64,471→ 64,471 total
Conversion
SANTARUS INC
Series C Preferred Stock
2004-04-06−1,617,795→ 0 total

Companies

Recent Filings

Address

C/O DOMAIN ASSOCIATES, LLC ONE PALMER SQUARE

PRINCETON, NJ, 08542

View on SEC.gov